共查询到19条相似文献，搜索用时 250 毫秒
1.
鸡大肠杆菌Ⅰ型菌毛亚单位苗交叉保护的初步研究 总被引：1，自引：0，他引：1
含Ⅰ型菌毛的３ 个不同血清型（Ｏ１ 、Ｏ７８ 及Ｏ８８） 的菌株， 大容量培养后提取菌毛制备３ 种单价菌毛油乳苗。用１ 日龄雏鸡分别免疫３ 种单价菌毛油乳剂苗， 每雏免疫量为１２５ μｇ ， 隔离饲养至２ 周龄经气囊攻毒， 并评价疫苗的免疫原性。结果未免疫鸡出现８７－５ ％ ～１００ ％ 的死亡率， 免疫鸡用同源菌株攻毒后死亡率仅１２－５ ％ ， 用异源菌株攻毒出现３７－５％ ～６２－５ ％ 的死亡率。免疫鸡攻毒后未死亡者， 经扑杀观察， 可见在气囊、心包及肝脏的病变非常轻微， 且攻毒后比非免疫鸡能更有效地清除攻入气囊的大肠杆菌 相似文献
2.
3.
用本地分离株及标准株筛选出 4个IBV强毒株 (呼吸型和腺胃型 )及 7个E .coli强毒菌株 (血清型为O1 、O2 、O78) ,作为制苗基础毒株和菌株 ,并加入发病鸡场的自家分离株 ,作为制苗毒种和菌种 ,并将制成灭活的尿囊液和菌液以及油佐剂配成鸡腺胃型传染性支气管炎及大肠杆菌病二联灭活油乳剂苗。试验证明 :二免后 10个月攻毒保护率达 10 0 % ,IBV抗体的HI价为 1∶2 5 6 ,E .coli抗体直接凝集价为 1∶12 8。 相似文献
4.
从山东省分离了６株鸡传染性鼻炎菌株,经过抗原比较,攻毒交叉保护试验,发现ＨＰＧ－ＨＺ株的保护性最佳,利用ＨＰＧ－ＨＺ株与标准Ａ型菌株ＨＰＧ－００８３株和标准Ｃ型菌株ＨＰＧ－Ｍｏｄｅｓｔｏ株结合,成功研制了鸡传染性鼻炎多价油乳剂灭活苗。将该疫苗在山东省、河北省、河南省等地共４５００万只鸡进行田间免疫试验和与同类疫苗的对比试验,结果表明,鸡传染性鼻炎多价油乳剂灭活苗对鸡群安全、有效,无副作用,免疫期可达６个月以上。特别对山东分离株的免疫保护比进口和国产同类疫苗均有优势。 相似文献
5.
微量凝集试验检测鸡大肠杆菌抗体方法的建立及应用 总被引：6，自引：0，他引：6
建立了检测鸡大肠杆菌（Ｅ．ｃｏｌｉ）抗 的微量凝集试验法，所用抗原由苗株制得。经方阵试验，抗原最适浓度为４０亿菌／ｍｌ，反应最佳时间为４小时。攻毒试验表明凝集抗体介在１：１６时免疫鸡保护率要达５０％以上，且凝集抗体水平与保护力呈明显正相关。经Ｅ．ｃｏｌｉ多价油乳剂灭活苗免疫的青年鸡在免疫后４２琦平均抗这７．２５ｌｏｇ２本法敏感性高、特异性强、染色抗原使结果判定更加客观和明显。为鸡大肠杆菌病的流行病 相似文献
6.
用分离的鸡大肠杆菌地方致病菌株与大肠杆菌标准菌株制备细菌悬液,细菌含量大于1.8×1010 个/mL,用 4 mL/L 浓度的甲醛溶液作用12 h,灭活后加入佐剂,制备鸡大肠杆菌多价灭活苗,免疫接种 10 日龄健康雏鸡,15 d后进行攻毒试验。结果表明,鸡大肠杆菌多价灭活苗的保护率可达98%。田间应用,鸡群产蛋期月死淘率由 1.5%~3%下降到0.5%~0.8%。 相似文献
7.
用从北京地区几家规模化猪场腹泻仔猪分离鉴定的大肠埃希氏O60、O141、0139、09和064制成多价油乳剂灭活苗，以0.2mL/只剂量免疫小白鼠，分别于免疫后7、14、30和60d攻毒，结果免疫14d后可获得100%保护；用该多价油乳剂灭活苗分别在母猪产前40d和15d肌肉注射2mL，对免疫母猪所产仔猪的保护率达95.0%以上。 相似文献
8.
9.
10.
鸡致病性大肠杆菌菌毛分型的初步研究 总被引：2，自引：0，他引：2
以鸡致病性大肠杆菌F1菌毛特异性单抗1F4－1、2C3、3H3和F11菌毛特异性单抗FA1、FB11作为检测试剂，将111株已知O抗原的鸡致病性大肠杆菌经MD液体培养基连续传代培养后，通过直接玻板凝集法对各菌毛进行初步分型。结果发现F1、F11菌毛与O78、O1及O2三种优势O抗原型菌株之间存在较为明显的相关性，即致病性大肠杆菌主要集中在上。F1、F11菌毛在这三种O抗原型上的总检出率分别为95．6％、75．4％及73．3％。另外，在所检测的111株鸡致病性大肠杆菌中，只表达F1菌毛的大肠杆菌占菌杆总数的33．3％。只表达F11菌毛的大肠杆菌占菌株总数的8．1％，两者都表达的占菌株总数的36％，F1、F11菌毛的总检出率为78．3％。 相似文献
11.
Immunogenicity of an oil-emulsified Escherichia coli multivalent pilus vaccine was evaluated in 4-week-old chickens. The vaccine contained 180 micrograms of pilus protein from each of serotypes O1 and O78 and 170 micrograms of pilus protein from serotype O2. Chickens were vaccinated twice subcutaneously at 4 and 6 weeks old and challenged via the posterior thoracic air sac with E. coli serotype O1, O2, or O78 2 weeks after the last vaccination. Unvaccinated challenged chickens suffered 8% to 26% mortality; no vaccinated chickens died. Vaccinated chickens had very mild gross lesions in the air sacs, livers, and pericardial sacs and eliminated E. coli more efficiently than the unvaccinated challenged chickens. The results showed that a multivalent pilus vaccine protects chickens against active respiratory infection. 相似文献
12.
Immunogenicity of an oil-emulsified Escherichia coli (serotype O1) pili vaccine was evaluated in chickens. Chickens were vaccinated with 116 micrograms or 29 micrograms of pili protein and challenged with the homologous E. coli via the posterior thoracic air sac. Unvaccinated chickens were challenged to serve as positive controls or left unchallenged to serve as negative controls. Vaccinated chickens were protected against challenge because they suffered low or no mortality; had mild gross lesions in air sacs, pericardial sacs, and livers, and the scored values were significantly (P less than or equal to 0.05) lower than those in the positive controls; and eliminated E. coli from tissues more efficiently than the positive controls. 相似文献
13.
Immunogenicity of an oil-emulsified Escherichia coli bacterin against heterologous challenge 总被引：1，自引：0，他引：1
Immunogenicity of an oil-emulsified Escherichia coli bacterin against heterologous challenge was investigated. In Expts. 1 and 2, chickens were vaccinated with E. coli serotype O1 bacterin and challenged with E. coli serotype O2 (Expt. 1) and O78 (Expt. 2). Positive control chickens were not vaccinated but challenged with E. coli serotype O2 or O78; unvaccinated unchallenged chickens served as negative controls. When challenged with E. coli serotype O2, unvaccinated chickens showed a higher morbidity than vaccinated chickens. There was no mortality in either group. Although average gross lesion scores were generally higher in the unvaccinated chickens, they were not significantly different (P greater than or equal to 0.05) from those in the vaccinated chickens. In Expt. 2, morbidity was slightly higher in the unvaccinated challenged chickens. No mortality occurred in either group. There was no significant difference (P greater than or equal to 0.05) between vaccinated and unvaccinated chickens in average gross lesion scores. In general, E. coli recovery was higher in the unvaccinated challenged chickens, being highest in the air sacs followed by the liver, heart blood, and pericardial sacs. There was no morbidity, mortality, or gross lesions in the unvaccinated unchallenged chickens. No E. coli was recovered from the tissues cultured. The results of these laboratory trials revealed that an oilemulsified monovalent E. coli bacterin did not protect chickens against other E. coli serotypes associated with colibacillosis. 相似文献
14.
Immunogenicity of an oil-emulsified Escherichia coli (O1:K1) bacterin with an aqueous-phase-to-oil-phase ratio of 1:4 was evaluated in chickens. Chickens were vaccinated subcutaneously with 0.5 ml of the bacterin at 4 and 6 weeks of age. At 8 weeks, the vaccinated chickens and unvaccinated controls were challenged via air sacs with 10(4) colony-forming units (CFU) of homologous E. coli. Vaccinated chickens were protected against active respiratory infection in that they (a) gained body weights comparable to those in unvaccinated, unchallenged chickens, (b) suffered no morbidity or mortality, (c) had gross lesions so mild that the scored values were comparable statistically to the 0 lesion scores of the negative controls, and (d) did not yield E. coli when their heart blood, pericardial sacs, livers, and air sacs were cultured. Unvaccinated challenged chickens had severe respiratory distress, suffered 36% mortality, and had average air sac, pericardial sac, and liver lesion scores significantly (P less than or equal to 0.05) different from both the vaccinated and negative control chickens. Also, the challenge strain of E. coli only was isolated from the affected tissues of 5 of 14 chickens. Protection against active respiratory infection was again demonstrated in a second experiment, though the challenge dose was 1.06 X 10(6) CFU of E. coli. The immunity, however, was partially overcome, as the vaccinated chickens gained less body weight and the scored values for lesions in the air sacs, pericardial sacs, and livers were significantly higher than those of the negative controls (P less than or equal to 0.05). 相似文献
15.
几种病毒与禽病原性大肠杆菌的人工联合感染 总被引：6，自引：0，他引：6
以2种剂量的低致病性禽流感病毒(lowly pathogenic avian influenza virus,LPAIV)，传染性支气管炎病毒（infectious bronchitis virus,IBV)疫苗株H120和H52，新城疫病毒（Newcastle disese viurs,NDV)Lasota株分别于气管内注射10日龄易感鸡，2d后，气管注射禽病原性大肠杆菌O37株（O78），连续观察5d，结果，除LPAIV单独感染组有6．25％的死亡率外，其余各病毒单独接种组均健活；大肠杆菌O37株单独接种组的死亡率为62．50％，较高剂量的LPAIV，IBV H120和H52，NDV Lasota株与大肠杆菌O37株有效强的协同致病作用，死亡率分别达到81.25%,100.00%,93.75%和87.50%，而较低剂量的上述病毒则无明显的协同作用，IBV，NDV疫苗株与大肠杆菌联合接种组的多数死亡鸡病程推迟。 相似文献
16.
禽大肠杆菌病免疫保护机理的研究 总被引：12，自引：2，他引：10
以禽病原性大肠杆菌O18、O78分离株制成超声波裂解铝佐剂灭活苗免疫14日龄鸡，以相同或不同外膜蛋白型（Outer membrane protein pattern,OMP型）的O18、O78分离株攻毒。结果表明：O78血清相同和不同OMP型分离株间能获得最大保护；O18血清型相同OMP型分离株间获得最大保护，而不同OMP型分离株间不能保护；上述两个血清型的分离株间不论OMP型是否相同，均缺乏保护。以间接ELISA试验、间接血凝试验分别测定了试验鸡临攻毒前针对大肠杆菌OMPs和脂多糖(Lipopolysaccharide,LPS）的抗体。结果表明：免疫组鸡血清上述两种抗体明显高于攻毒对照组；在免疫组，存活鸡临攻毒前血清中上述两种抗体滴度恒高于死亡鸡，但除3个组外，多数组差异不显著。攻毒对照组这一关系不稳定。结果说明：禽大肠杆菌疫苗的免疫保护，主要与O血清型有关，部分与OMP型有关，如O18分离株，免疫保护性抗原含OMPs,LPS等多个抗原表位。 相似文献
17.
The objective of this study was to characterize virulence factors of Escherichia coli isolates from broilers with simultaneous occurrence of cellulitis and other colibacillosis lesions. Thirty flocks were sampled and 237 birds with cellulitis were examined. Eighty-two (34.6%) of 237 birds condemned for cellulitis had gross lesions in the heart, air sacs, joints, or liver. In 58 chickens, E. coli was isolated from both the cellulitis and other lesions of colibacillosis, and 18.9% of the E. coli isolates from the 2 types of lesions belonged to the same O group. Escherichia coli of serogroups O78, O1, and O2 predominated. Isolates of the same serogroup that were derived from different lesions in the same birds had similar patterns of biotype, aerobactin production, serum sensitivity profile, antibiotic sensitivity, and K1 capsule production. Escherichia coli derived from cellulitis lesions produced virulence factors similar to those found in E. coli isolated from other colibacillosis lesions in poultry. 相似文献
18.
Relationship of complement resistance and selected virulence factors in pathogenic avian Escherichia coli. 总被引：5，自引：0，他引：5
Complement resistance, antibiotic resistance profiles, and virulence profiles of 80 Escherichia coli isolates from the intestines of normal chickens (40 isolates) and chickens diagnosed as having colisepticemia (40 isolates) were compared. Differences were observed between the two groups for antibiotic resistance, siderophore production, presence of type 1 pili, complement resistance, motility, and size of plasmids. The systemic isolates were more likely to have siderophores and type 1 pili, and to be complement-resistant and motile than were the intestinal isolates. No differences between the two groups were observed for colicin production. Further comparison of the 10 most complement-resistant isolates from the systemic group and 10 most complement-sensitive isolates from the intestinal group revealed a correlation between an isolate's resistance to complement and its ability to kill embryos, express type 1 pili, and be motile. Virulence of avian E. coli strains appears to be correlated with complement resistance and the interaction of this resistance with the ability to produce type 1 pili and be motile. 相似文献
19.
This study determined optimal conditions for experimental reproduction of colibacillosis by aerosol administration of avian pathogenic Escherichia coli to 2-to-4-wk-old broiler chickens. The basic model for reproducing disease was intranasal administration of approximately 10(4) mean embryo infectious dose of infectious bronchitis virus (IBV) followed by aerosol administration of an 02 or an 078 strain of E. coli in a Horsfall unit (100 ml of a suspension of 10(9) colony-forming units/ml over 40 min). Scores were assigned to groups of infected chickens on the basis of deaths; frequency and severity of lesions in the air sacs, liver and heart; and recovery of the challenge E. coli 6 days post-E. coli infection. An interval of 4 days between the IBV and E. coli challenges was best whether the chickens received the IBV at 8 or 20 days of age. Typically, 50%-80% of the chickens developed airsacculitis and 0 to 29% of the chickens developed pericarditis or perihepatitis, with little or no mortality. Escherichia coli alone resulted in no deaths and 0 to 20% airsacculitis, but these percentages increased to 0 to 5% and 52%-60% when the E. coli aerosol was administered through a cone-shaped chamber. Administration of IBV alone failed to induce lesions. Recovery of the challenge E. coli from chickens did not correlate well with lesions. On the basis of these data, administration of IBV to 20-day-old chickens followed 4 days later by exposure to an avian pathogenic E. coli reproduces avian colibacillosis with the low mortality, high percentage of airsacculitis, and low percentage of septicemic lesions characteristic of the conditions seen in the natural disease. 相似文献